Citadel Advisors’s Parexel International Corp PRXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-46,433
| Closed | -$4.09M | – | 8827 |
|
|
2017
Q3 | $4.09M | Buy |
46,433
+43,943
| +1,765% | +$3.85M | ﹤0.01% | 2519 |
|
|
2017
Q2 | $216K | Sell |
2,490
-424,828
| -99% | -$31.7M | ﹤0.01% | 6450 |
|
|
2017
Q1 | $27M | Buy |
427,318
+361,467
| +549% | +$23.9M | 0.02% | 772 |
|
|
2016
Q4 | $4.33M | Sell |
65,851
-2,113
| -3% | -$133K | ﹤0.01% | 2148 |
|
|
2016
Q3 | $4.72M | Buy |
67,964
+50,886
| +298% | +$3.44M | ﹤0.01% | 2045 |
|
|
2016
Q2 | $1.07M | Buy |
+17,078
| New | +$1.06M | ﹤0.01% | 3465 |
|
|
2016
Q1 | – | Sell |
-103,184
| Closed | -$6.36M | – | 8788 |
|
|
2015
Q4 | $7.03M | Buy |
+103,184
| New | +$6.71M | 0.01% | 1533 |
|
|
2015
Q2 | – | Sell |
-5,689
| Closed | -$383K | – | 9334 |
|
|
2015
Q1 | $392K | Sell |
5,689
-6,201
| -52% | -$395K | ﹤0.01% | 5287 |
|
|
2014
Q4 | $661K | Sell |
11,890
-325,894
| -96% | -$18.8M | ﹤0.01% | 4332 |
|
|
2014
Q3 | $21.3M | Buy |
337,784
+278,973
| +474% | +$15.9M | 0.02% | 867 |
|
|
2014
Q2 | $3.11M | Sell |
58,811
-17,576
| -23% | -$882K | ﹤0.01% | 2294 |
|
|
2014
Q1 | $4.13M | Sell |
76,387
-162,251
| -68% | -$8.31M | ﹤0.01% | 1947 |
|
|
2013
Q4 | $10.8M | Buy |
+238,638
| New | +$10.9M | 0.01% | 1165 |
|
|
2013
Q3 | – | Sell |
-5,549
| Closed | -$255K | – | 6990 |
|
|
2013
Q2 | $255K | Buy |
+5,549
| New | +$244K | ﹤0.01% | 4448 |
|
Other funds holding PRXL
Citadel Advisors's PRXL Position: Q4 2017 in Review
Citadel Advisors sold out of Parexel International Corp (PRXL) in Q4 2017, closing a stake of 46,433 shares — an estimated $4.09M sold.
Citadel Advisors first reported a position in PRXL in Q2 2013 and held it in 14 quarters. The position peaked at $27M in Q1 2017. 1 fund tracked by Wall St. Rank holds PRXL as of Q4 2017.
- Citadel Advisors reported no remaining Parexel International Corp position as of Q4 2017 after selling out during the quarter.
- Citadel Advisors sold 46,433 Parexel International Corp shares in Q4 2017, an estimated $4.09M.
- Citadel Advisors first reported a position in Parexel International Corp in Q2 2013 and held it in 14 quarters.
- Citadel Advisors's Parexel International Corp position peaked at $27M in Q1 2017.
- 1 fund tracked by Wall St. Rank held Parexel International Corp as of Q4 2017.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.